Here is what has occurred and what patients may expect in the coming months based on manufacturer announcements and regulatory filings: December 22, 2025: FDA approved oral Wegovy (semaglutide 25 mg), the first oral GLP-1 for weight loss
Dosage Calculator When it comes to dosing, this will vary depending on an individuals goals, health, and age
Your choice of binding buffer will influence the binding capacity of the beads , so if you are capturing substantially less than 8 mg of protein per mL of resin, and your protein isnt really big, then it is worth considering if your binding buffer is limiting the capture efficiency of the beads
Dose adjustments, anti-nausea medications, or dietary counseling with a registered dietitian may be appropriate
Taken together, there are clear opportunities for food companies wishing to position themselves as health and wellness brands to reach the consumer demographic in this case, younger to middle-aged males that is the most commonly affected by diabetes
